Literature DB >> 25433793

[Contribution of pleural fluid analysis to the diagnosis of pleural effusion].

Lucía Ferreiro1, María Elena Toubes1, Luis Valdés2.   

Abstract

Analysis of pleural fluid can have, on its own, a high diagnostic value. In addition to thoracocentesis, a diagnostic hypothesis based on medical history, physical examination, blood analysis and imaging tests, the diagnostic effectiveness will significantly increase in order to establish a definite or high probable diagnosis in a substantial number of patients. Differentiating transudates from exudates by the classical Light's criteria helps knowing the pathogenic mechanism resulting in pleural effusion, and it is also useful for differential diagnosis purposes. An increased N-terminal pro-brain natriuretic peptide, both in the fluid and in blood, in a due clinical context, is highly suggestive of heart failure. The presence of an increased inflammatory marker, such as C-reactive protein, together with the presence of over 50% of neutrophils is highly suggestive of parapneumonic pleural effusion. If, in these cases, the pH is<7.20, then the likelihood of complicated pleural effusion is high. There remains to be demonstrated the usefulness of other markers to differentiate complicated from uncomplicated effusions. An adenosine deaminase > 45 U/L and>50% lymphocytes is suggestive of tuberculosis. If a malignant effusion is suspected but the cytological result is negative, increased concentrations of some markers in the pleural fluid can yield high specificity values. Increased levels of mesothelin and fibruline-3 are suggestive of mesothelioma. Immunohistochemical studies can be useful to differentiate reactive mesothelial cells, mesothelioma and metastatic adenocarcinoma. An inadequate use of the information provided by the analysis of pleural fluid would results in a high rate of undiagnosed effusions, which is unacceptable in current clinical practice.
Copyright © 2014 Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Analysis of pleural fluid; Análisis del líquido pleural; Derrame pleural; Derrame pleural neoplásico; Derrame pleural paraneumónico; Derrame pleural tuberculoso; Diagnosis of pleural effusion; Diagnóstico del derrame pleural; Malignant pleural effusion; Parapneumonic pleural effusion; Pleural effusion; Tuberculous pleural effusion

Mesh:

Substances:

Year:  2014        PMID: 25433793     DOI: 10.1016/j.medcli.2014.08.005

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  4 in total

1.  Homocysteine: new tumor marker in pleural fluid.

Authors:  Jose D Santotoribio; Consuelo Cañavate-Solano; Angela Garcia-de la Torre; Luis Del Valle-Vazquez; Francisco Arce-Matute; Juan F Cuadros-Muñoz; Maria J Sanchez del Pino; Manuel J Bandez-Ruiz; Carmen Piñuela-Rojas; Santiago Perez-Ramos
Journal:  Tumour Biol       Date:  2015-05-09

2.  The diagnostic value of pleural fluid homocysteine in malignant pleural effusion.

Authors:  Jose D Santotoribio; Luis Del Valle-Vazquez; Angela García-de la Torre; Daniel Del Castillo-Otero; Juan-Bosco Lopez-Saez; Maria J Sanchez Del Pino
Journal:  PLoS One       Date:  2019-09-24       Impact factor: 3.240

3.  Diagnostic value of tumour markers in pleural effusions.

Authors:  Darian Volarić; Veljko Flego; Gordana Žauhar; Ljiljana Bulat-Kardum
Journal:  Biochem Med (Zagreb)       Date:  2018-01-10       Impact factor: 2.313

4.  Effectiveness and Safety of Real-Time Transthoracic Ultrasound-Guided Thoracentesis.

Authors:  Marco Sperandeo; Carla Maria Irene Quarato; Rosario Squatrito; Paolo Fuso; Lucia Dimitri; Anna Simeone; Stefano Notarangelo; Donato Lacedonia
Journal:  Diagnostics (Basel)       Date:  2022-03-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.